A promising drug that may halt Alzheimer’s: Standing by his side

A new study, conducted by researchers at the University College London School of Pharmacy, has found a link between the use of drugs for erectile dysfunction and a reduced risk of dementia. The study lasted for five years and included almost 270,000 men with an average age of 58 years who were diagnosed with erectile dysfunction but did not have cognitive problems at the start of the study.

The research findings showed that among men who were treated with drugs for erectile dysfunction, the rate of dementia cases was 120% lower compared to those who were not treated with drugs. Those who received the most medication prescriptions and took the correct dose per month were at the lowest risk of developing dementia. However, the researchers explained that these findings do not prove that the drugs themselves reduce the risk of dementia, but rather suggest a new direction for research into the mechanisms behind dementia and how blood vessel-dilating drugs may affect it.

Dr. Kobi Reisman, a specialist in urology and sexual therapy, and director of the European Academy of Sexual Medicine, explains that previous laboratory studies have shown that drugs such as Viagra have anti-inflammatory properties and can prevent deposit formation in the brain that leads to Alzheimer’s disease. He also emphasizes that Viagra is not a treatment for Alzheimer’s disease but highlights a clear connection between erectile dysfunction and human health. Among about 70% of men with erectile dysfunction, heart disease will appear within five years.

In conclusion, while this study does not prove a direct cause-and-effect relationship between erectile dysfunction medications and reduced risk of dementia, it does provide evidence for further research into this area. It also underscores the importance of addressing erectile dysfunction as part of a comprehensive approach to overall health and wellbeing.

By Editor

Leave a Reply